Peroral dosage form for peptide containing medicaments, in particular insulin
US6468959B1 · kind B1 · utility
24Cited by
8References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 1994 |
| Grant date | Oct 22, 2002 |
| Priority date | — |
| Expiry date | Apr 5, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4891
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a plural dosage form for peptide pharmaceuticals comprising a matrix of gelatin or gelatin derivative having distributed therein the peptide pharmaceutical in particular insulin, as well as, pharmaceutically conventional carriers and additives. By selection of the appropriate gelatin the pharmaceutical is liberated in the small intestine or the large intestine so that is not enzymatically degraded anymore by peptidases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.